Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells—a type of cancer ...

INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK ... Michael Dickinson, MBBS, FRACP, Lead of the Aggressive Lymphoma Disease Group at Peter ...

Scientists have engineered CAR-T cells with on/off switches activated by existing drugs, enhancing safety in cancer therapy.

given the multitude of vaccine approaches currently being tested and the even greater number of vaccine target antigens being evaluated. In a recent report by the National Cancer Institute ...

Utilizing an analytic hierarchy process (AHP) based on preidentified criteria and weighted by a panel of experts, Cheever and colleagues constructed priority rankings of 75 cancer antigens.

Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a 'magic bullet' strategy ...

If prostate cancer spreads to other parts of the body, it can become deadly and commonly moves to bones, the lungs, lymph ...

The first patient has been successfully imaged, marking a milestone in the development of this copper-based ...

Behind breast cancer, prostate cancer is the second most common cancer in the United States. Since its opening in 2012, the ...

Olympian Chris Hoy has raised awareness of the common cancer since revealing his terminal diagnosis this weekend.